Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Price83.95 -1.05 (-1.24%)52 Week High108.00
ISININE947I0101752 Week Low55.20
IndustryMedical/Nursing ServicesVolume3,374
SectorHealth ServicesP/E Ratio TTM42.72
Market Cap1.7 B1 Year Beta0.68
Technical Rating of

Lotus Eye Hospital and Institute Limited (LOTUSEYE) is an Indian eye care hospital chain headquartered in Chennai, Tamil Nadu. It was founded in 1986 by Dr. V. G. Raman. LOTUSEYE is one of the leading eye care hospital chains in India.

LOTUSEYE offers a range of eye care services, including:

  • Cataract surgery: LOTUSEYE offers cataract surgery for a wide range of cataract conditions.
  • Refractive surgery: LOTUSEYE offers refractive surgery for a wide range of vision correction conditions.
  • Glaucoma surgery: LOTUSEYE offers glaucoma surgery for a wide range of glaucoma conditions.

LOTUSEYE is a well-managed company with a strong track record of financial performance. The company has been profitable for over 35 years and has a strong balance sheet. LOTUSEYE is also one of the leading eye care hospital chains in India.

Here are some of the key aspects of Lotus Eye Hospital and Institute Limited (LOTUSEYE):

  • Products and services: LOTUSEYE offers a range of eye care services, including cataract surgery, refractive surgery, and glaucoma surgery.
  • Customers: LOTUSEYE’s customers include a wide range of individuals and families in India and abroad.
  • Financial performance: LOTUSEYE has been profitable for over 35 years and has a strong balance sheet.
  • Market share: LOTUSEYE is one of the leading eye care hospital chains in India. It has a market share of over 5% of the Indian eye care market.
  • Growth potential: LOTUSEYE is well-positioned to grow in the coming years, due to the increasing demand for eye care services in India and abroad.

However, there are also some risks associated with investing in LOTUSEYE. These risks include:

  • Competition: LOTUSEYE faces competition from other Indian and international eye care hospital chains.
  • Regulation: The eye care industry is regulated by the government of India and other countries. This regulation could impact LOTUSEYE’s business in the future.
  • Economic slowdown: If the Indian or global economy slows down, it could impact LOTUSEYE’s business.
  • Changing technologies: The eye care industry is constantly evolving with new technologies. LOTUSEYE needs to be able to adapt to these changes in order to remain competitive.

Overall, Lotus Eye Hospital and Institute Limited (LOTUSEYE) is a well-managed company with a strong track record of financial performance. The company is also one of the leading eye care hospital chains in India. However, there are also some risks associated with investing in LOTUSEYE, such as competition, regulation, economic slowdown, and changing technologies.

          

Technical Analysis of Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Marubozu Black
Marubozu Black is formed on Lotus Eye Hospital and Institute Limited (LOTUSEYE) in 1 Day Timeframe. This is a red candlestick that has no shadow extending from the body either at the open or the close. In Japanese, the name means “close-cropped” or “close-cut.” The candlestick can also be referred to as Bald or Shaven Head.

Moving Averages

PeriodSimpleExponential
MA 585.3285.17
MA 1086.5886.07
MA 2087.6487.11
MA 3087.1687.60
MA 5090.4487.19
MA 10083.7583.82
MA 20076.9278.43

Moving Average Rating

Technical Indicators

NameValueNameValue
Aroon Up (14)0.00Aroon Down (14)100.00
MACD Level (12, 26)-1.15MACD Signal (12, 26)-0.81
Relative Strength Index (7)33.77Relative Strength Index (14)41.28
Stochastic %D (14 3 3)8.72Stochastic %K (14 3 3)6.56
Stochastic RSI Fast (3, 3, 14, 14)16.05Stochastic RSI Slow (3, 3, 14, 14)20.27
Bollinger Upper Band (20)92.18Bollinger Lower Band (20)83.09
Keltner Channels Upper Band (20)91.57Keltner Channels Lower Band (20)82.65
Donchian Channels Upper Band (20)94.60Donchian Channels Lower Band (20)81.00
Ichimoku Conversion Line (9, 26, 52, 26)86.97Ichimoku Base Line (9, 26, 52, 26)86.65
Ichimoku Leading Span A (9, 26, 52, 26)96.05Ichimoku Leading Span B (9, 26, 52, 26)89.13
Positive Directional Indicator (14)18.55Negative Directional Indicator (14)28.93
Volume Weighted Average Price84.28Volume Weighted Moving Average 2088.76

Oscillator Rating

Oscillators

Awesome Oscillator-3.51
Ultimate Oscillator (7,14,28)31.67
Money Flow (14)23.03
Chaikin Money Flow (20)0.01
Commodity Channel Index (20)-111.78
Bull Bear Power-3.98

High / Low

1 Month94.6080.35
3 Month108.0074.95
6 Month108.0055.20
52 Week108.0055.20
All Time108.004.50

Volume

Volume3,374.00
Average 10 D3,186.20
Average 30 D15,633.87
Average 60 D33,836.17
Average 90 D30,650.31

Change/Volatility

Change-1.05 (-1.24%)
Change 1W-2.60 (-3.00%)
Change 1M-5.85 (-6.51%)
Volatility1.25
Volatility W1.23

Performance

Yesterday9.60
Weekly-1.24
Monthly1.88
3 Month-1.24
6 Month34.32
Yearly29.15
5 Year228.57
All Time109.87

Misc.

Average Day Range (14)1.16
Average Directional Index (14)17.81
Average True Range (14)2.75
Williams Percent Range (14)-100.00
Rate Of Change (9)-6.62
Hull Moving Average (9)84.53
Momentum (10)-4.20
Parabolic SAR92.67

PIVOT POINTS of Lotus Eye Hospital and Institute Limited (LOTUSEYE)

NameS3S2S1Pivot PointsR1R2R3
Classic33.5762.8776.3392.17105.63121.47150.77
Fibonacci62.8774.0680.9792.17103.36110.27121.47
Camarilla81.7484.4387.1192.1792.4995.1797.86
Woodie's47.0562.8776.3592.17105.65121.48134.95
DeMark's - - 69.6088.8098.90 - -

Financial Analysis of Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Income Statement

Basic EPS (FY)1.96
Basic EPS (TTM)1.97
EBITDA (Annual YoY Growth)27.66
EBITDA (Quarterly QoQ Growth)71.10
EBITDA (Quarterly YoY Growth)2.34
EBITDA (TTM)76.4 M
EBITDA (TTM YoY Growth)-4.67
EPS Diluted (Annual YoY Growth)36.58
EPS Diluted (FY)1.96
EPS Diluted (Quarterly QoQ Growth)114.65
EPS Diluted (Quarterly YoY Growth)0.91
EPS Diluted (TTM)1.97
EPS Diluted (TTM YoY Growth)-10.22
Free Cash Flow (Annual YoY Growth)5,254.19
Free Cash Flow Margin (FY)3.53
Gross Profit (Annual YoY Growth)37.47
Gross Profit (FY)132 M
Gross Profit (MRQ)37.6 M
Gross Profit (Quarterly QoQ Growth)41.78
Gross Profit (Quarterly YoY Growth)0.73
Gross Profit (TTM YoY Growth)-2.49
Last Year Revenue (FY)470.4 M
Revenue (Annual YoY Growth)20.90
Revenue (Quarterly QoQ Growth)12.52
Revenue (Quarterly YoY Growth)5.84
Revenue (TTM YoY Growth)6.41
Net Income (Annual YoY Growth)36.63
Net Income (FY)40.8 M
Net Income (Quarterly QoQ Growth)113.70
Net Income (Quarterly YoY Growth)0.91
Net Income (TTM YoY Growth)-10.16
Total Revenue (FY)470.4 M

Valuation

Enterprise Value/EBITDA (TTM)22.58
Number of Shareholders6,830.00
Price to Earnings Ratio (TTM)42.72
Price to Revenue Ratio (TTM)3.66
Total Shares Outstanding20.8 M
Selling & Admin expenses Ratio (FY)18.26
Selling & Admin expenses Ratio (TTM)18.06

Balance Sheet

Total Assets (Annual YoY Growth)2.58
Total Debt (Annual YoY Growth)-45.85
Total Liabilities (FY)56.1 M
Cash & Equivalents (FY)84.1 M
Cash and short term investments (FY)84.1 M

Operating Metrics

Dividends

Dividend Yield Forward0.60
Dividends Paid (FY)-10,398,000.00
Dividends per Share (FY)0.50

Margins

Net Margin (FY)8.67
Net Margin (TTM)8.57
Gross Margin (FY)28.05
Gross Margin (TTM)27.72
Operating Margin (FY)9.79
Operating Margin (TTM)9.66
Pretax Margin (TTM)11.99

Related Companies (Peers) to Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Price2,339.60 -51.35 (-2.15%)52 Week High2,750.00
ISININE600L0102452 Week Low1,762.05
IndustryMedical/Nursing ServicesVolume177.9 T
SectorHealth ServicesP/E Ratio TTM73.86
Market Cap199.4 B1 Year Beta0.54
Technical Rating of
Dr. Lal Path Labs Ltd. (LALPATHLAB) is an Indian diagnostic laboratory chain. It was founded in 1983 and is headquartered in Delhi, India. LALPATHLAB is one of the largest diagnostic laboratory chains in India, with a presence in over 1,600 locations across the country. The company’s services include a wide range of diagnostic tests, including more about Dr. Lal Path Labs Ltd. (LALPATHLAB)

Price650.25 -2.35 (-0.36%)52 Week High699.70
ISININE08LI0102052 Week Low353.10
IndustryMedical/Nursing ServicesVolume53,955
SectorHealth ServicesP/E Ratio TTM33.30
Market Cap20.4 B1 Year Beta-0.62
Technical Rating of
Krsnaa Diagnostics Limited (KRSNAA) is a diagnostic imaging and pathology services provider based in India. It was founded in 2009 by Dr. Ashish Jain and is headquartered in Pune, Maharashtra. The company has a network of over 100 diagnostic centers across India. KRSNAA’s services include: Radiology: Krsnaa Diagnostics offers a range of radiology services, including more about Krsnaa Diagnostics Limited (KRSNAA)

Price137.10 -2.55 (-1.83%)52 Week High195.00
ISININE0CG60101652 Week Low76.00
IndustryMedical/Nursing ServicesVolume114,048
SectorHealth ServicesP/E Ratio TTM
Market Cap6 B1 Year Beta1.26
Technical Rating of
Max India Limited (MAXIND) is an Indian integrated healthcare company that was founded in 1981 and is headquartered in New Delhi, India. The company is one of the leading integrated healthcare companies in India. MAXIND has a strong focus on the Indian market. The company has a deep understanding of the Indian healthcare industry and more about Max India Limited (MAXIND)

Price1,417.75 -3.15 (-0.22%)52 Week High1,791.20
ISININE112L0102052 Week Low1,171.35
IndustryMedical/Nursing ServicesVolume168 T
SectorHealth ServicesP/E Ratio TTM52.67
Market Cap72.7 B1 Year Beta0.71
Technical Rating of
Metropolis Healthcare Limited (METROPOLIS) is an Indian diagnostic chain. The company was founded in 1998 and is headquartered in Mumbai, Maharashtra. Metropolis Healthcare Limited is one of the leading diagnostic chains in India. The company has a strong focus on the Indian market. The company has a deep understanding of the Indian diagnostic market and more about Metropolis Healthcare Limited (METROPOLIS)

Price562.45 -6.35 (-1.12%)52 Week High768.25
ISININE594H0101952 Week Low415.40
IndustryMedical/Nursing ServicesVolume42,818
SectorHealth ServicesP/E Ratio TTM53.85
Market Cap30.1 B1 Year Beta0.68
Technical Rating of
Thyrocare Technologies Limited (THYROCARE) is an Indian diagnostic laboratory chain headquartered in Mumbai, India. The company was founded in 1996 and is one of the leading diagnostic laboratory chains in India. THYROCARE offers a wide range of diagnostic tests, including: Blood tests: THYROCARE offers a range of blood tests, including complete blood count (CBC), liver more about Thyrocare Technologies Limited (THYROCARE)

Price455.60 -10.05 (-2.16%)52 Week High529.00
ISININE043W0102452 Week Low349.25
IndustryMedical/Nursing ServicesVolume101,003
SectorHealth ServicesP/E Ratio TTM49.96
Market Cap47.5 B1 Year Beta0.60
Technical Rating of
Vijaya Diagnostic Centre Limited (VIJAYA) is an Indian diagnostic laboratory chain headquartered in Hyderabad, Telangana, India. It was founded in 1981 by Dr. K. Vijayanand. VIJAYA is a leading diagnostic laboratory chain in India. It has a network of over 200 laboratories across India. The company offers a wide range of diagnostic tests, including: Blood more about Vijaya Diagnostic Centre Limited (VIJAYA)

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Sectors
Stock Industries